Rh Incompatibility in Pregnancy: Mechanism, Risks, and Prevention with RhoGAM

Rh incompatibility occurs when an Rh-negative mother carries an Rh-positive fetus (inherited from an Rh-positive father). It is a leading cause of hemolytic disease of the fetus and newborn (HDFN), preventable with modern prophylaxis.

The Rh Factor

  • Protein (D antigen) on red blood cell surface.
  • Rh-positive (Rh+): Antigen present (~85% Caucasians, ~90–95% Black/Asian).
  • Rh-negative (Rh−): Antigen absent.

Mechanism of Sensitization

  1. Fetal Rh+ red cells enter maternal circulation (fetomaternal hemorrhage).
  2. Maternal immune system recognizes D antigen as foreign → produces anti-D IgG antibodies.
  3. IgG crosses placenta (unlike IgM) → binds fetal Rh+ RBCs → hemolysis.
  4. Subsequent Rh+ pregnancies: faster, stronger antibody response (anamnestic) → more severe HDFN.

When Fetomaternal Hemorrhage Occurs

  • Delivery (vaginal or C-section) — most common/largest volume.
  • Miscarriage, abortion, ectopic pregnancy.
  • Amniocentesis, CVS, cordocentesis.
  • Abdominal trauma.
  • External cephalic version.
  • Antepartum (silent, small volume) — ~1–2% of pregnancies.

Consequences of HDFN (Untreated)

  • Fetal anemia: Hemolysis → high-output cardiac failure → hydrops fetalis (edema, ascites, effusions) → fetal demise.
  • Hyperbilirubinemia: Hemolysis → bilirubin → kernicterus (bilirubin encephalopathy) → cerebral palsy, hearing loss, death.
  • Neonatal anemia: Persists after birth; may need transfusion.

Prevention: Rho(D) Immune Globulin (RhoGAM®)

  • Mechanism: Passive anti-D IgG coats fetal Rh+ cells in maternal circulation → clears them before maternal immune system recognizes them → prevents active sensitization.
  • Standard Protocol (US):
    • Routine at 28 weeks gestation (300 µg IM).
    • Within 72 hours postpartum if infant is Rh+ (300 µg IM).
    • After any sensitizing event (miscarriage, abortion, amnio, trauma, ECV) — dose per gestational age.
  • Efficacy: Reduced alloimmunization from ~13–16% to <0.1–0.2%.
  • Safety: Human plasma derivative; viral inactivation; no live virus risk.

If Already Sensitized (Anti-D Positive)

  • RhoGAM is ineffective (cannot reverse active immunization).
  • Monitor: Serial maternal anti-D titers (critical titer ~1:16–1:32).
  • Fetal assessment: MCA Doppler (peak systolic velocity) for anemia; amniocentesis (ΔOD450) — largely replaced by Doppler.
  • Treatment: Intrauterine transfusion (IUT) for fetal anemia; early delivery; phototherapy/exchange transfusion for neonate.

Other Blood Group Systems

Kell, Duffy, Kidd, MNS, etc. can also cause HDFN. Kell is 2nd most clinically significant. Antibody screening (indirect Coombs) at first prenatal visit detects all clinically significant antibodies.

Bottom line: Rh incompatibility is almost entirely preventable with timely RhoGAM. All Rh− pregnant women should receive standard prophylaxis. Know your blood type and antibody screen results.

Blood Disorders - Related Articles